Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03611231
What this trial is testing

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Who this might be right for
Experimental Tumor
Peking University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableUnknownNCT01596192
What this trial is testing

PETCT for Diagnosing and Monitoring Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
Rabin Medical Center 30
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03346135
What this trial is testing

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaSecondary Amyloidosis
City of Hope Medical Center 31
Not applicableEnded earlyNCT02240381
What this trial is testing

Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

Who this might be right for
Diabetes MellitusMalignant Neoplasm
Vanderbilt-Ingram Cancer Center 22
Not applicableStudy completedNCT03188419
What this trial is testing

Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Who this might be right for
Primary T-cell Immunodeficiency DisordersCommon Variable Immunodeficiency
National Cancer Institute (NCI) 161
Early research (Phase 1)WithdrawnNCT07498465
What this trial is testing

Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChildhood Acute Lymphoblastic Leukemia+3 more
Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Large-scale testing (Phase 3)Study completedNCT02312258
What this trial is testing

Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Takeda 706
Testing effectiveness (Phase 2)Looking for participantsNCT06717958
What this trial is testing

Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation

Who this might be right for
AMLMDS
Technische Universität Dresden 76
Early research (Phase 1)Looking for participantsNCT05443425
What this trial is testing

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT02389517
What this trial is testing

Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

Who this might be right for
Plasma Cell MyelomaResidual Disease
University of Chicago 42
Testing effectiveness (Phase 2)UnknownNCT01369368
What this trial is testing

Treatment of Acute Leukemia Relapse After Allotransplantation

Who this might be right for
Acute Myeloid Leukemia
University of Bergen 20
Not applicableEnded earlyNCT00578461
What this trial is testing

T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE

Who this might be right for
LeukemiaCancerLymphoma+2 more
Baylor College of Medicine 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06617286
What this trial is testing

CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
New York Medical College 21
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Early research (Phase 1)UnknownNCT00002616
What this trial is testing

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Illinois at Chicago 36
Testing effectiveness (Phase 2)WithdrawnNCT04312789
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Platelet Disorder
Ayman Saad
Early research (Phase 1)Study completedNCT03932643
What this trial is testing

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University of Nebraska 20
Next Page